Favipiravir, an antiviral for COVID-19?

J Antimicrob Chemother. 2020 Jul 1;75(7):2013-2014. doi: 10.1093/jac/dkaa171.
No abstract available

MeSH terms

  • Amides / therapeutic use*
  • Antiviral Agents / therapeutic use*
  • Betacoronavirus / drug effects
  • COVID-19
  • Clinical Trials as Topic
  • Coronavirus Infections / drug therapy*
  • Humans
  • Pandemics
  • Pneumonia, Viral / drug therapy*
  • Pyrazines / therapeutic use*
  • SARS-CoV-2

Substances

  • Amides
  • Antiviral Agents
  • Pyrazines
  • favipiravir

Supplementary concepts

  • COVID-19 drug treatment